Phathom Pharmaceuticals
USEntry
2019
Hold
<1yr
Exit
2019
Who owns Phathom Pharmaceuticals?
Phathom Pharmaceuticals was owned by Abingworth through Abingworth Bioventures VII (2018 vintage) from 2019 to 2019, exited via IPO.
Hand-verified · updated 2026-06-10
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2019
More from Abingworth Bioventures VII
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
Track Phathom Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Phathom Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue